We use cookies for a better user experience. Read our Privacy Policy

I Agree

Bioanalytical Services Market Forecast Report, 2021-2031

Bioanalytical Services Market (Services: Immunochemistry Services, Quantitative Immunoassays, Cell-based Neutralization Assays, LCMS Method Development, Discovery Phase Bioanalysis, LCMS Sample Bioanalysis, GCP Bioanalysis Service, Biomarker Assays, Protein Analysis, and Others; Type: Small Molecule Bioanalysis, Large Molecule Bioanalysis, and Others; and End-user: Pharma & Biotechnology Companies, Contract Research Organizations, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Accelerating Bioanalytical Services to Reduce COVID-19 Impact

The bioanalytical services market is expected to witness abundance of growth opportunities in the upcoming years. The increasing number of infectious diseases is anticipated to revive the growth of the bioanalytical services market. Many pharmaceutical companies are now collaborating with research institutes to provide necessary bioanalyical services. Bioanalytical services involve pre-clinical tests, fluid or specimen testing, analysis of clinical samples, investigation of infection of viruses in the body, etc. In the global pandemic, these services have created significant growth opportunities for market contributors. Bioanalytical services played a major role in COVID-19 drug investigation and vaccination programs. Ongoing assays, vaccine testing solutions, drug inspection procedures, and technological advancement in pharmaceutical companies are creating revenue opportunities amid pandemic in the bioanalytical services market.

bioanalytical services market infographic

Request a sample to get extensive insights into the Bioanalytical Services Market

Overcoming Challenges in Bioanalytical Services Market

Dearth of highly skilled and productive manpower is one of the major challenges faced by many market contributors of the bioanaytical services market. Bioanalytical laboratories and research centers require skilled and experienced professionals to study and develop innovative solutions to fulfill the increasing demand of bioanalytical testing services from medical industry. In order to overcome this, governments are investing on providing training, webinars for students and graduate-level scientists to educate and keep themselves updated with the latest trends, and recent technological advancements. Moreover, to minimize the complexities in bioanalytics, acceptance and investment in new technologies, making use of better tools, and equipment for accurate sample analysis are required.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Emerging Contact Research Organizations (CRO) in Pharmaceuticals

The bioanalytical services market is projected to reach US$ 12.34 Bn by 2031. Manufacturers are bolstering their R&D capabilities to experiment with new technologies and applications. Escalating complexity and number of standards are driving the bioanalytical services market. Pharmaceutical companies are establishing their foot in outsourcing R&D activities to various contact research organizations to stay ahead of the competition and generate more revenue opportunities. Increasing government expenditure on healthcare, research & development activities, and trending advances in bioinformatics also strengthen the scope and expansion of CROs. Oncology is also a highly demanding branch of medicine that deals in diagnosis and treatment of cancer. The introduction of Big Data and artificial intelligence in medical field also elevate the demand in the bioanalytical services market.

Rising Prevalence of Infectious Diseases and Bioanalytical Services

Research & development activities have gained momentum in the field of drug development life cycles, pharmaceuticals, biopharmaceuticals, vaccinating procedures, and biosimilars since the coronavirus pandemic outbreak. The bioanalytical services have played an important role in the mitigation of the COVID-19 pandemic. Prevention and control of future waves of the various other infectious diseases such as SARS-CoV-2, HIV, etc. is extremely necessary these days, and thus, bioanalytical testing services are advantageous in many ways. There is an increasing demand for small molecular and large molecular bioanalytical services such as electrophoresis, tissue bioanalysis, immunochemistry services, electrochemical and titrimetric assays, immunoassays, etc. The high demand for these services are translating into lucrative revenue opportunities for manufacturers in the bioanalyttical services market.

Initiatives by Governments to Support R&D Activities

The bioanalytical services market is expected to advance at a CAGR of 8.2% during the forecast period. Pharmaceutical companies are increasing their output capacities in pre-clinical testing methods, drug safety, etc. with changing guidelines of international organizations. Thus, to understand the complex and changing standards in testing methods, clinical trials, and regulatory updates, governments are taking a step ahead to support manufacturers in the pharmaceutical companies, and investing in research and development activities. Bianalytical services are beneficial in early detection of coronavirus, and governments of various countries are supporting for the same. Increasing healthcare expenditure, outsourcing research activities by pharmaceutical companies in the bioanalytical services market help elevate the economy.

Rapid Growth & Development in North America Creating Profitable Revenue Opportunities

The increasing prevalence of infectious as well as chronic diseases such as diabetes all over the world demand for bioanalytical testing services. A large number of ongoing clinical trials, outsourcing services, research activities, and increasing investment by major pharmaceutical companies are some of the factors responsible for the growth of the bioanalytical services market in North America. The rapid increase in manufacturing of pharmaceuticals to fulfill consistently rising demand for healthcare services in the region is expected to propel the development of the bioanalytics services market in the region.

Manufacturers operating in the bioanalytical services market are shifting toward electronics medical devices to increase the performance of the services. Countries in the Asia Pacific market such as China, India, Japan, etc. are the fastest growing markets in providing and outsourcing bioanalytical services. Increasing investments on healthcare and highly efficient pharmaceutical outsourcing services are the two important factors that are boosting the market growth in Asia Pacific.

bioanalytical services market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Bioanalytical Services Market

Analysts’ Viewpoint

Experienced scientists are developing innovative methods to detect drug metabolites, drug analysis, and validation requirements by considering various regulatory and non-regulatory guidelines and standardizations. Drug samples can be analyzed by ensuring the quality, stability, and accuracy. Technological advancements in healthcare and pharmaceutical industries have the potential to create more revenue opportunities post COVID-19 period. Although there are some challenges in the bioanalytical services market that we need to overcome in the upcoming years such as lack of skilled professionals, methods to deal with highly complex, unstable drug compounds, etc. Hence, companies in the bioanalytical services market should experiment with new techniques to improvise the testing processes. In addition, elemental bioanalysis, biosimilar analysis, and validation methods are also contributing toward market expansion.

Bioanalytical Services Market: Overview

  • This report analyzes the current scenario and future prospects of the global bioanalytical services market. Increase in demand for bioanalytical testing services can be attributed to the rise in prevalence of infectious diseases, HIV, and other diseases. Additionally, surge in government initiatives to control outbreaks of infectious diseases such as coronavirus is projected to drive the global bioanalytical services market during the forecast period.
  • The report provides an elaborate executive summary, including a snapshot of various segments of the bioanalytical services market. It also provides elaborate information and data analysis of the global bioanalytical services market with regard to segments based on service, type, end-user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers and restraints, and opportunities that affect the global bioanalytical services market
  • Additionally, the report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the bioanalytical services market
  • The report on the global bioanalytical services market offers market attractiveness analysis of the regions and segments
  • The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global bioanalytical services market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global bioanalytical services market.

Bioanalytical Services Market: Key Segments

  • In terms of service, the global bioanalytical services market has been classified into immunochemistry services, quantitative immunoassays, cell-based neutralization assays, LCMS method development, discovery phase bioanalysis, LCMS sample bioanalysis, GCP bioanalysis service, biomarker assays, protein analysis, and others. The immunochemistry service segment held major share of the global bioanalytical services market in 2020, and the trend is anticipated to continue during the forecast period.
  • Based on type, the global bioanalytical services market has been categorized into small molecule analysis, large molecule analysis, and others. The small molecule analysis segment accounted for majority of the market share in 2020.
  • Based on end-user, the global bioanalytical services market has been divided into pharma & biotechnology companies, contract research organization, and others
  • The market value and forecast for each of these segments have been provided from 2017 to 2031. The CAGRs of respective segments have also been provided from 2021 to 2031, considering 2017 to 2019 as the historical years and 2020 as base year.

Bioanalytical Services Market: Regional Outlook

  • The global bioanalytical services market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The bioanalytical services market report provides value and forecast for each region and country/sub-region from 2017 to 2031. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2021 to 2031. The bioanalytical services market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global bioanalytical services market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global bioanalytical services market report are
    • PPD, Inc.
    • ICON plc
    • Laboratory Corporation of America
    • Charles River Laboratories International, Inc.
    • Syneos Health
    • SGS SA Toxikon, Inc.
    • Intertek Group
    • Pace Analytical Services
    • Medpace
    • PRA HEALTH SCIENCES
    • WuXi AppTec
    • IQVIA
    • Eurofins Scientific

Bioanalytical Services Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 5.4 Bn

Market Forecast Value in 2031

USD$ 12.4 Bn

Growth Rate (CAGR)

8.2%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Service
    • Immunochemistry Services
    • Quantitative Immunoassays
    • Cell-based Neutralization Assays
    • LCMS Method Development
    • Discovery Phase Bioanalysis
    • LCMS Sample Bioanalysis
    • GCP Bioanalysis Service
    • Biomarker Assays
    • Protein Analysis
    • Others
  • Type
    • Small Molecule Bioanalysis
    • Large Molecule Bioanalysis
    • Others
  • End-user
    • Pharma & Biotechnology Companies
    • Contract Research Organizations
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Japan
  • China
  • India
  • Australia
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Customization Scope

Available upon request

Pricing

Available upon request

Bioanalytical Services Market – Segmentation

Service
  • Immunochemistry Services
  • Quantitative Immunoassays
  • Cell-based Neutralization Assays
  • LCMS Method Development
  • Discovery Phase Bioanalysis
  • LCMS Sample Bioanalysis
  • GCP Bioanalysis Service
  • Biomarker Assays
  • Protein Analysis
  • Others
Type
  • Small Molecule Bioanalysis
  • Large Molecule Bioanalysis
  • Others
End-user
  • Pharma & Biotechnology Companies
  • Contract Research Organizations
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Bioanalytical Services Market Forecast Report, 2021-2031

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of bioanalytical services market?

Bioanalytical services market is projected to reach US$ 12.34 Bn by 2031

What is the anticipated CAGR of the bioanalytical services market in the forecast period?

Bioanalytical services market is projected to expand at a CAGR of 8.2% from 2021 to 2031

What are the key driving factors for the growth of the bioanalytical services market?

Bioanalytical services market is driven by rise in prevalence of infectious diseases, HIV, and other diseases.

Which is the rising prominent segment in the bioanalytical services market?

The small molecule bioanalysis segment dominated the global bioanalytical services market and the trend is likely to continue during the forecast period.

Who are the key players in the global bioanalytical services market?

Key Players in bioanalytical services market include PPD, Inc., ICON plc, Laboratory Corporation of America, Charles River Laboratories International, Inc., Syneos Health, SGS SA

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioanalytical Services Market

4. Market Overview

    4.1. Introduction

        4.1.1. Services Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Bioanalytical Services Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.3. Technological Advancements

6. Global Bioanalytical Services Market Analysis and Forecast, by Service

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Services, 2017–2031

        6.3.1. Immunochemistry Service

        6.3.2. Quantitative Immunoassays

        6.3.3. Cell-Based Neutralization Assays

        6.3.4. LCMS Method Development

        6.3.5. Discovery Phase Bioanalysis

        6.3.6. LCMS Sample Bioanalysis

        6.3.7. GCP Bioanalysis Service

        6.3.8. Biomarker Assays

        6.3.9. Protein Analysis

        6.3.10. Others

    6.4. Market Attractiveness By Service

7. Global Bioanalytical Services Market Analysis and Forecast, by Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Type, 2017–2031

        7.3.1. Small Molecule Bioanalysis

        7.3.2. Large Molecule Bioanalysis

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by Type

8. Global Bioanalytical Services Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Pharma & Biotechnology Companies

        8.3.2. Contract Research Organizations

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Bioanalytical Services Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Bioanalytical Services Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Service, 2017–2031

        10.2.1. Immunochemistry Service

        10.2.2. Quantitative Immunoassays

        10.2.3. Cell-Based Neutralization Assays

        10.2.4. LCMS Method Development

        10.2.5. Discovery Phase Bioanalysis

        10.2.6. LCMS Sample Bioanalysis

        10.2.7. GCP Bioanalysis Service

        10.2.8. Biomarker Assays

        10.2.9. Protein Analysis

        10.2.10. Others

    10.3. Market Value Forecast, by Type, 2017–2031

        10.3.1. Small Molecule Bioanalysis

        10.3.2. Large Molecule Bioanalysis

        10.3.3. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Pharma & Biotechnology Companies

        10.4.2. Contract Research Organizations

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Service

        10.6.2. By Type

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Bioanalytical Services Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Service, 2017–2031

        11.2.1. Immunochemistry Service

        11.2.2. Quantitative Immunoassays

        11.2.3. Cell-Based Neutralization Assays

        11.2.4. LCMS Method Development

        11.2.5. Discovery Phase Bioanalysis

        11.2.6. LCMS Sample Bioanalysis

        11.2.7. GCP Bioanalysis Service

        11.2.8. Biomarker Assays

        11.2.9. Protein Analysis

        11.2.10. Others

    11.3. Market Value Forecast, by Type, 2017–2031

        11.3.1. Small Molecule Bioanalysis

        11.3.2. Large Molecule Bioanalysis

        11.3.3. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Pharma & Biotechnology Companies

        11.4.2. Contract Research Organizations

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. U.K.

        11.5.2. Germany

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Service

        11.6.2. By Type

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Bioanalytical Services Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Service, 2017–2031

        12.2.1. Immunochemistry Service

        12.2.2. Quantitative Immunoassays

        12.2.3. Cell-Based Neutralization Assays

        12.2.4. LCMS Method Development

        12.2.5. Discovery Phase Bioanalysis

        12.2.6. LCMS Sample Bioanalysis

        12.2.7. GCP Bioanalysis Service

        12.2.8. Biomarker Assays

        12.2.9. Protein Analysis

        12.2.10. Others

    12.3. Market Value Forecast, by Type, 2017–2031

        12.3.1. Small Molecule Bioanalysis

        12.3.2. Large Molecule Bioanalysis

        12.3.3. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Pharma & Biotechnology Companies

        12.4.2. Contract Research Organizations

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. India

        12.5.3. Japan

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Service

        12.6.2. By Type

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Bioanalytical Services Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Service, 2017–2031

        13.2.1. Immunochemistry Service

        13.2.2. Quantitative Immunoassays

        13.2.3. Cell-Based Neutralization Assays

        13.2.4. LCMS Method Development

        13.2.5. Discovery Phase Bioanalysis

        13.2.6. LCMS Sample Bioanalysis

        13.2.7. GCP Bioanalysis Service

        13.2.8. Biomarker Assays

        13.2.9. Protein Analysis

        13.2.10. Others

    13.3. Market Value Forecast, by Type, 2017–2031

        13.3.1. Small Molecule Bioanalysis

        13.3.2. Large Molecule Bioanalysis

        13.3.3. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Pharma & Biotechnology Companies

        13.4.2. Contract Research Organizations

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Service

        13.6.2. By Type

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Bioanalytical Services Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Service, 2017–2031

        14.2.1. Immunochemistry Service

        14.2.2. Quantitative Immunoassays

        14.2.3. Cell-Based Neutralization Assays

        14.2.4. LCMS Method Development

        14.2.5. Discovery Phase Bioanalysis

        14.2.6. LCMS Sample Bioanalysis

        14.2.7. GCP Bioanalysis Service

        14.2.8. Biomarker Assays

        14.2.9. Protein Analysis

        14.2.10. Others

    14.3. Market Value Forecast, by Type, 2017–2031

        14.3.1. Small Molecule Bioanalysis

        14.3.2. Large Molecule Bioanalysis

        14.3.3. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Pharma & Biotechnology Companies

        14.4.2. Contract Research Organizations

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Service

        14.6.2. By Type

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix

    15.2. Market Share Analysis, by Company, 2020

    15.3. Competitive Business Strategies

    15.4. Company Profiles

        15.4.1. PPD, Inc.

            15.4.1.1. Company Description

            15.4.1.2. Business Overview

            15.4.1.3. Financial Overview

            15.4.1.4. SWOT Analysis

        15.4.2. ICON plc

            15.4.2.1. Company Description

            15.4.2.2. Business Overview

            15.4.2.3. Financial Overview

            15.4.2.4. SWOT Analysis

        15.4.3. Laboratory Corporation of America

            15.4.3.1. Company Description

            15.4.3.2. Business Overview

            15.4.3.3. Financial Overview

            15.4.3.4. SWOT Analysis

        15.4.4. Charles River Laboratories International, Inc.

            15.4.4.1. Company Description

            15.4.4.2. Business Overview

            15.4.4.3. Financial Overview

            15.4.4.4. SWOT Analysis

        15.4.5. Syneos Health

            15.4.5.1. Company Description

            15.4.5.2. Business Overview

            15.4.5.3. Financial Overview

            15.4.5.4. SWOT Analysis

        15.4.6. SGS SA

            15.4.6.1. Company Description

            15.4.6.2. Business Overview

            15.4.6.3. SWOT Analysis

        15.4.7. Toxikon, Inc.

            15.4.7.1. Company Description

            15.4.7.2. Business Overview

            15.4.7.3. SWOT Analysis

        15.4.8. Intertek Group

            15.4.8.1. Company Description

            15.4.8.2. Business Overview

            15.4.8.3. Financial Overview

            15.4.8.4. SWOT Analysis

        15.4.9. Pace Analytical Services

            15.4.9.1. Company Description

            15.4.9.2. Business Overview

            15.4.9.3. SWOT Analysis

        15.4.10. Medpace

            15.4.10.1. Company Description

            15.4.10.2. Business Overview

            15.4.10.3. Financial Overview

            15.4.10.4. SWOT Analysis

        15.4.11. PRA HEALTH SCIENCES

            15.4.11.1. Company Description

            15.4.11.2. Business Overview

            15.4.11.3. Financial Overview

            15.4.11.4. SWOT Analysis

        15.4.12. WuXi AppTec

            15.4.12.1. Company Description

            15.4.12.2. Business Overview

            15.4.12.3. Financial Overview

            15.4.12.4. SWOT Analysis

        15.4.13. IQVIA

            15.4.13.1. Company Description

            15.4.13.2. Business Overview

            15.4.13.3. Financial Overview

            15.4.13.4. SWOT Analysis

        15.4.14. Eurofins Scientific

            15.4.14.1. Company Description

            15.4.14.2. Business Overview

            15.4.14.3. Financial Overview

            15.4.14.4. SWOT Analysis

List of Tables

Table 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 02: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 03: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 07: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 11: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 12: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 15: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 16: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 19: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 20: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 23: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 24: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Bioanalytical Services Market Value Share, by Type, 2020

Figure 03: Global Bioanalytical Services Market Value Share, by Region, 2020

Figure 04: Global Bioanalytical Services Market Value Share, by Service, 2020

Figure 05: Global Bioanalytical Services Market Value Share, by End-user, 2020

Figure 06: Global Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 07: Global Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 08: Global Bioanalytical Services Market Revenue (US$ Mn), by Immunochemistry Services, 2017–2031

Figure 09: Global Bioanalytical Services Market Revenue (US$ Mn), by Quantitative Immunoassays, 2017–2031

Figure 10: Global Bioanalytical Services Market Revenue (US$ Mn), by Cell-Based Neutralization Assays, 2017–2031

Figure 11: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Method Development, 2017–2031

Figure 12: Global Bioanalytical Services Market Revenue (US$ Mn), by Discovery Phase Bioanalysis, 2017–2031

Figure 13: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Sample Bioanalysis, 2017–2031

Figure 14: Global Bioanalytical Services Market Revenue (US$ Mn), by GCP Bioanalysis Service, 2017–2031

Figure 15: Global Bioanalytical Services Market Revenue (US$ Mn), by Biomarker Assays, 2017–2031

Figure 16: Global Bioanalytical Services Market Revenue (US$ Mn), by Protein Analysis, 2017–2031

Figure 17: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

Figure 18: Global Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 19: Global Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 20: Global Bioanalytical Services Market Revenue (US$ Mn), by Small Molecule Bioanalysis, 2017–2031

Figure 21: Global Bioanalytical Services Market Revenue (US$ Mn), by Large Molecule Bioanalysis, 2017–2031

Figure 22: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

Figure 23: Global Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 24: Global Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 25: Global Bioanalytical Services Market Value (US$ Mn), by Pharma & Biotechnology Companies, 2017–2031

Figure 26: Global Bioanalytical Services Market Value (US$ Mn), by Contract Research Organizations, 2017–2031

Figure 27: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

Figure 28: Global Bioanalytical Services Market Value Share Analysis, by Region, 2020 and 2031

Figure 29: Global Bioanalytical Services Market Attractiveness Analysis, by Region, 2021–2031

Figure 30: North America Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 31: North America Bioanalytical Services Market Value Share, by Country, 2020–2031

Figure 32: North America Bioanalytical Services Market Attractiveness Analysis, by Country, 2021–2031

Figure 33: North America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 34: North America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 35: North America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 36: North America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 37: North America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 38: North America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 39: Europe Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Europe Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 41: Europe Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 42: Europe Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 43: Europe Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 44: Europe Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 45: Europe Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 46: Europe Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 47: Europe Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 48: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 49: Asia Pacific Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 50: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 51: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 52: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 53: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 54: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 55: Asia Pacific Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 56: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 58: Latin America Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031

Figure 59: Latin America Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 60: Latin America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 61: Latin America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 62: Latin America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 63: Latin America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 64: Latin America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 65: Latin America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 66: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 67: Middle East & Africa Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031

Figure 68: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 69: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 70: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 71: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 72: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 73: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 74: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

774

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved